Should I buy Carlisle Companies (CSL) stock or is it too late?
⭐ The most reliable of them, either direction: Truist Securities — 69% of its targets hit on this sector (204 calls tested). It aims for $340 (-5.7 %), call made on July 8, 2026, maturing on July 8, 2027 (51 d ago).
Firm-by-firm track record on Carlisle Companies
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Credit Suisse | 83 % | +44.9 % | 6 | $300 -17% |
| BMO Capital | 100 % | +38.9 % | 7 | $310 -14% |
| Oppenheimer | 62 % | +20.7 % | 21 | $425 +18% |
| Baird | 45 % | +7.8 % | 20 | $405 +12% |
✅ Reasons to believe
- 60% of analysts rate it a buy (Buy consensus, 5 ratings) — a sign of market conviction.
- Median price target $410, i.e. +14% from the current price ($361).
- The most reliable firm on CSL, Oppenheimer (62% hit rate, 21 scored calls), targets $425 (call made on April 24, 2026, maturing on April 24, 2027) (+18%) in its most recent call, and $415 (call made on October 20, 2025, maturing on October 20, 2026) (+15%) in the one coming due soonest.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 5 ratings, 2 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on CSL
Median target $410 (+14%) · 5 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Carlisle Companies now?
We won't decide for you. The facts: 60% of analysts rate it a buy, median target $410 (+14%), and Oppenheimer (most reliable on CSL, 62%) targets $425. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in Carlisle Companies?
Not according to analysts: the median target ($410) is still +14% above the current price ($361) (most reliable on CSL: Oppenheimer, 62%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Carlisle Companies still worth investing in?
It depends on the gap between the price ($361) and its estimated value: analysts target $410 on median (+14%), with 60% buys (most reliable on CSL: Oppenheimer, 62%). Cross-check with their real reliability on CSL and the cautions above. Information, not advice.
What's the main risk in buying CSL?
The consensus is not unanimous: of 5 ratings, 2 are neutral.
→ Go deeper: the full Carlisle Companies profile (consensus, analyst reliability, price target, performance).